29 Jul, 2025 New Data Supporting the Development of Mivelsiran, an Investigational CNS-targeting RNAi Therapeutic, Presented at the Alzheimer’s Association International Conference 2025

body

Cohen, et al. “Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer’s Disease”

Taillie, et al. “Small Interfering RNA Targeting Amyloid-Beta Precursor Protein Reduces Alzheimer’s Disease Pathology in 5xFAD Mice”